Osteoporosis treatment: raloxifene (Evista) and stroke mortality.
Wooltorton
Eric
E
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000009:adverse effects*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects*; D020521:Stroke / Q000139:chemically induced*
D050071:Bone Density Conservation Agents; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride